Study shows lasting T-cell immunity in healthcare workers against SARS-CoV-2 variants

Study reveals robust memory T-cell responses to SARS-CoV-2 in healthcare workers over 1.5 years post-Omicron, suggesting durable immunity against highly mutated variants.

Medtech venture investment recovery continues, but startup M&A remains limited: Pitchbook

Dive Brief: Venture capital investment in medtech companies rose roughly 3% year over year to $3.3 billion in the second quarter, according to a new

September 4, 2024

First-Line Triplet Yields ‘Striking’ OS Result in Extensive-Stage SCLC

SINGAPORE — Adding the investigational combination of PD-L1 inhibitor benmelstobart and antiangiogenic tyrosine kinase inhibitor anlotinib to first-line chemotherapy significantly improved survival in extensive-stage small-cell

September 12, 2023

Why clinicians are reconsidering race-based algorithms

Algorithms are ubiquitous in medicine. They can take the form of a flowchart, a simple equation, or a complicated AI model, and are used to

September 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.